Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an announcement.
Wai Chun Bio-Technology Limited has announced a delay in sending a shareholder circular related to a previously disclosed loan agreement and associated non-compliance with listing rules. The company now expects to dispatch the circular, which will include further financial details of the drawdowns under the loan agreement, on or before 27 January 2026 instead of the earlier target of 6 January 2026, as it requires additional time to prepare and finalise the necessary financial information, potentially affecting the timing of investor access to full disclosure on the transaction.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 660. It operates under the oversight of a board led by chairman and chief executive officer Lam Ka Chun, with a mix of executive and independent non-executive directors providing corporate governance for its activities in the market.
Average Trading Volume: 88,492
Technical Sentiment Signal: Hold
Current Market Cap: HK$33.55M
For an in-depth examination of 0660 stock, go to TipRanks’ Overview page.